Quantitative decrease of apolipoprotein-A1 by cohort. by Thierry Poynard (38084)

Decrease of apolipoprotein-A1 by gender and age in US cohort. by Thierry Poynard (38084)

Trace-weighted images at b = 50 s/mm². by Tobit Führes (12647099)

Subjects:

Effectiveness of interventions to decrease hesitancy. by Maximilian Nicolaus Burger (12969212)

COVID-19 incidence increases over time with a decreased importance of genetic COVID-19 susceptibility. by C. A. Robert Warmerdam (12568808)

“…The error bars represent the 95% confidence interval for the regression coefficients. The plot shows a decrease in the variance explained by the PGS during the COVID-19 pandemic.…”

Maximum IFN concentrations are decreased in severe patients. by Sonia T. Gazeau (21512764)

Naringenin decreases mitochondrial function. by Lauren A. Eanes (20995499)

Exposure profiles for 100 agents are arranged in decreasing order then averaged. by Riti Bahl (11292441)

Decrease in circulating iNKT cell activation during regadenoson (RA) infusion into patients with COVID-19. by Joseph Rabin (7399436)

Decreased test sensitivity: Screening the whole population. by Timo de Wolff (9904467)

Long COVID prevalence decreases with vaccine uptake, globally. by Manlio De Domenico (626037)

Subjects:

Long COVID prevalence decreases with vaccine uptake in the U.S. by Manlio De Domenico (626037)

Subjects:

Initiation of corticosteroid therapy resulted in a decrease in IP-10 levels (ICU patients, n = 12). by Shaul Lev (779105)

Prevalence of top ten words presented in decreasing order of frequency for each cohort. by Zoe Bradfield (10428658)

HSP90 inhibition by RGRN-305 and 17-AAG decreased proinflammatory protein secretion. by Hakim Ben Abdallah (14578241)

Prevalence of smoking during COVID19 (n = 1844). by Mahmoud A. Alomari (14780446)

“…</p><p>Conclusions</p><p>Changes in the SH during COVID-19 have been reported in about 50% of participants who smoke tobacco, with a more reported decrease than increase in use. …”

Confinement information due to COVID19 (n = 1844). by Mahmoud A. Alomari (14780446)

Image_1_Decreased Endometrial Thickness Is Associated With Higher Risk of Neonatal Complications in Women With Polycystic Ovary Syndrome.tif by Jialyu Huang (6742409)

“…</p>Results<p>Each millimeter decrease in EMT was related to a 9% (adjusted OR 1.09, 95% CI 1.00–1.19; P = 0.053), 14% (adjusted OR 1.14, 95% CI 1.02–1.28; P = 0.002) and 22% (adjusted OR 1.22, 95% CI 1.07–1.38; P = 0.003) higher risk of PTB, LBW and SGA, respectively. …”

Image_2_Decreased Endometrial Thickness Is Associated With Higher Risk of Neonatal Complications in Women With Polycystic Ovary Syndrome.tif by Jialyu Huang (6742409)

“…</p>Results<p>Each millimeter decrease in EMT was related to a 9% (adjusted OR 1.09, 95% CI 1.00–1.19; P = 0.053), 14% (adjusted OR 1.14, 95% CI 1.02–1.28; P = 0.002) and 22% (adjusted OR 1.22, 95% CI 1.07–1.38; P = 0.003) higher risk of PTB, LBW and SGA, respectively. …”

Table_1_Decreased Endometrial Thickness Is Associated With Higher Risk of Neonatal Complications in Women With Polycystic Ovary Syndrome.docx by Jialyu Huang (6742409)

“…</p>Results<p>Each millimeter decrease in EMT was related to a 9% (adjusted OR 1.09, 95% CI 1.00–1.19; P = 0.053), 14% (adjusted OR 1.14, 95% CI 1.02–1.28; P = 0.002) and 22% (adjusted OR 1.22, 95% CI 1.07–1.38; P = 0.003) higher risk of PTB, LBW and SGA, respectively. …”